RxDoctor Payments Data

Matthew Weiss, MD

Surgical Oncology · New Hyde Park, NYNPI 1568416618

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Histosonics, Inc. accounts for 87.3% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $4,299, more than ten times the $64 reported in 2019.

$4,899in general payments, 2019–2025

Across 11 payments — averaging $445.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Histosonics, Inc.$4K
  • Intera Oncology, Inc$137
  • AstraZeneca$135
  • Trisalus Life Sciences, Inc.$123
  • AbbVie$123
  • Amarin Pharma, Inc.$43
  • plus $60 from 3 others

What the payments were for

  • Consulting fees$2,00041%
  • Travel & lodging$1,67034%
  • Food & beverage$1,22925%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,899 in reported general payments places this provider in the 75th percentile of 173 surgical oncology providers in New York.

See all surgical oncology providers in New York

Medicare billing

Part B allowed, 2024
$155,572
Medicare patients
197
Services billed
349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in New Hyde Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →